Murine Surgical Model of Topical Elastase Induced Descending Thoracic Aortic Aneurysm
August 24th, 2019
7.5K views
We describe a surgical protocol to consistently induce robust descending thoracic aortic aneurysms in mice. The procedure involves left thoracotomy, thoracic aorta exposure, and placement of a sponge soaked in porcine pancreatic elastase on the aortic wall.
Overview
This article describes a surgical protocol for inducing robust descending thoracic aortic aneurysms in mice. The method involves left thoracotomy and the application of porcine pancreatic elastase to the aortic wall.
Key Study Components
Area of Science
- Neuroscience
- Cardiovascular research
- Animal models
Background
- Thoracic aortic aneurysms are significant cardiovascular conditions.
- Existing models may lack consistency in aneurysm size and location.
- Reliable protocols are essential for studying aneurysm development.
- This study aims to provide a straightforward surgical approach.
Purpose of Study
- To establish a consistent method for inducing thoracic aortic aneurysms in mice.
- To improve the reliability of animal models for cardiovascular research.
- To facilitate safe access to the murine chest during surgical procedures.
Methods Used
- Induction of anesthesia in male C57BL/6 mice.
- Positioning of the mouse for optimal surgical access.
- Left thoracotomy to expose the thoracic aorta.
- Application of a sponge soaked in porcine pancreatic elastase to the aortic wall.
Main Results
- The protocol consistently produces robust thoracic aortic aneurysms.
- Aneurysms are of predictable size and location.
- The method is straightforward and efficient compared to other models.
- Safe access to the murine chest is achieved through this protocol.
Conclusions
- This surgical protocol is effective for inducing thoracic aortic aneurysms in mice.
- It provides a reliable model for future cardiovascular studies.
- Further research can build upon this method to explore aneurysm pathophysiology.
Frequently Asked Questions
What is the significance of this protocol?
It provides a reliable method for studying thoracic aortic aneurysms in mice, which is crucial for cardiovascular research.
How does this method compare to other models?
This protocol is more straightforward and produces consistent results in terms of aneurysm size and location.
What type of anesthesia is used?
An appropriate level of sedation is confirmed before the procedure, ensuring the mouse is safely anesthetized.
What are the key steps in the surgical procedure?
Key steps include left thoracotomy, exposure of the thoracic aorta, and application of elastase.
What age and strain of mice are used?
The protocol is designed for eight to ten-week-old male C57BL/6 mice.
Is this protocol safe for the animals?
Yes, the protocol is designed to ensure safe access to the murine chest during the procedure.
Executive Industry Relevance
This murine model enables mechanistic investigation of descending thoracic aortic aneurysm (dTAA) pathophysiology, supporting target validation and preclinical de-risking of therapeutic candidates. By providing a reproducible system for aneurysm formation, it facilitates evaluation of genetic and pharmacological interventions aimed at inhibiting aneurysm progression or rupture. The model’s consistency in aneurysm size and location enhances predictive confidence in translational cardiovascular research.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of molecular pathways involved in aortic wall degradation and inflammatory response.
- Operational Value: Supports functional validation of targets such as interleukin-1β and interleukin-6 in dTAA pathogenesis.
Screening & Assay Development
- Scientific Value: Provides a standardized biological system for assessing compound effects on aneurysm growth and stability.
- Operational Value: Facilitates assay readiness through quantifiable aortic diameter measurements via video micrometry.
Translational & Preclinical Research
- Scientific Value: Models human dTAA pathophysiology, including elastin fragmentation and macrophage infiltration.
- Operational Value: Enables longitudinal monitoring of aneurysm development to inform dosing and timing of interventions.
Pipeline & Workflow Integration
The model fits within the discovery continuum from target validation through preclinical efficacy testing, particularly for cardiovascular indications involving vascular remodeling and inflammation.
- Discovery Biology: Supports hypothesis testing regarding protease-mediated extracellular matrix degradation in aneurysm formation.
- Screening: Delivers reproducible phenotypic output (aortic dilation) for compound library screening.
- Analytics: Generates quantitative dependent variable measurements (aneurysm diameter) essential for dose-response analysis.
- Translational Research: Mirrors key histological features of human dTAA, supporting biomarker alignment and mechanism-of-action studies.
- Enterprise Reuse: Serves as a reusable platform for evaluating multiple therapeutic targets across discovery campaigns.
Operational & Enterprise Impact
- Scientific Value: Mechanistic de-risking through elucidation of inflammatory mediators like IL-1β and IL-6 in dTAA progression.
- Operational Value: Standardized surgical procedure ensures reproducibility across laboratories and study timelines.
- Strategic Value: Improves go/no-go decisions by reducing biological uncertainty in vascular target validation.
- Portfolio Impact: Enables risk-adjusted prioritization of candidates based on aneurysm growth inhibition or rupture prevention.
Implementation Considerations
- Requires expertise in murine thoracic surgery and microsurgical techniques.
- Dependent on precision instrumentation including rib retractors, forceps, and video micrometry systems.
- Necessitates standardized postoperative care and monitoring to ensure animal welfare and data integrity.
- Adaptation to other models or strains may require validation of aneurysm penetrance and kinetics.
- Limited by species-specific differences in aortic physiology and elastase sensitivity between mice and humans.
Biopharma FAQs
Why is aneurysm diameter measurement critical for target validation?
Quantitative assessment of aortic dilation via video micrometry provides a dependent variable to evaluate therapeutic efficacy. Changes in aneurysm size relative to controls enable dose-response analysis and target engagement confirmation. This metric supports go/no-go decisions in preclinical programs.
How does isolation of the aortic wall as an independent variable improve mechanistic studies?
By applying elastase directly to the exposed aortic adventitia, the model isolates vascular tissue injury from systemic confounders. This enables precise attribution of observed phenotypes to local protease activity and downstream signaling. Such control enhances target validation confidence in pathway-specific interventions.
What histological outputs enable assessment of therapeutic mechanisms in this model?
Histological analysis evaluates elastin integrity, smooth muscle cell content, and macrophage infiltration as indicators of aneurysm stability. Increases in IL-1β and IL-6 expression further inform inflammatory pathway involvement. These outputs support mechanism-of-action studies and biomarker alignment.
Why are replication requirements essential for cross-functional collaboration in aneurysm research?
Consistent aneurysm size and location across animals ensure reproducibility between discovery, preclinical, and translational teams. Reliable phenotypic output reduces variability in compound testing and target validation efforts. This consistency supports aligned decision-making across functions.
What statistical analysis capabilities are required to interpret aneurysm development data?
Longitudinal tracking of aortic dilation requires repeated measures analysis to compare treated and control groups over time. Significance testing at key timepoints (e.g., day 14) determines therapeutic effect robustness. Such analyses are necessary to establish predictive confidence in target modulation.
